← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 15, 2020Last known activity
Aug 6, 2025
Timeline
2010s
- Jun 1, 2018
Erasca, Inc.— Founded
Drugs by trial phase (16 distinct, 10 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (12)
- NCT07021898OfficialPhase 1Aug 6, 2025
- NCT07021898Lead sponsorPhase 1Aug 6, 2025
- NCT06983743OfficialPhase 1Jun 5, 2025
- NCT06983743Lead sponsorPhase 1Jun 5, 2025
- NCT06346067Lead sponsorPhase 3Apr 29, 2024
- NCT05907304Lead sponsorPhase 1Aug 17, 2023
- NCT05279859Lead sponsorPhase 1/Phase 2Mar 15, 2022
- NCT05222802Lead sponsorPhase 1Feb 25, 2022
- NCT05039177Lead sponsorPhase 1/Phase 2Sep 20, 2021
- NCT04959981Lead sponsorPhase 1/Phase 2Sep 2, 2021
- NCT04866134Lead sponsorPhase 1/Phase 2May 7, 2021
- NCT04670679Lead sponsorPhase 1Dec 15, 2020
Details
- Founded
- San Diego, CA, US Jun 1, 2018
- Last known activity
- Aug 6, 2025